Hereditary sensory autonomic neuropathy type II: Report of two novel mutations in the FAM134B gene.


Journal

Journal of the peripheral nervous system : JPNS
ISSN: 1529-8027
Titre abrégé: J Peripher Nerv Syst
Pays: United States
ID NLM: 9704532

Informations de publication

Date de publication:
12 2019
Historique:
received: 10 08 2019
revised: 27 09 2019
accepted: 30 09 2019
pubmed: 10 10 2019
medline: 11 8 2020
entrez: 10 10 2019
Statut: ppublish

Résumé

Hereditary sensory autonomic neuropathy (HSAN) type II is a rare, autosomal recessive, and early onset sensory neuropathy, characterized by severe and progressive sensation impairment, leading to ulcero-mutilating complications. FAM134B gene, also known as RETREG1 gene, mutations have been reported to be associated to HSAN-IIB. We report four patients from two unrelated families who developed during childhood a sensory axonal neuropathy with variable severity and pronounced nociception impairment. Complications such as recurrent ulcerations, osteomyelitis, and osteonecrosis leading to distal amputation were noticed. Dysautonomia was mild or even absent in our group of patients. Additionally, either clinical or neurophysiological motor impairment was not uncommon. Presence of upper motor neuron signs was also a distinctive feature in two related patients. After extensive workup, two novel homozygous mutations in the FAM134B gene were identified. This report expands the clinical and genetic spectrum of HSAN type II and emphasizes the phenotype variability even within the same family.

Identifiants

pubmed: 31596031
doi: 10.1111/jns.12352
doi:

Substances chimiques

Intracellular Signaling Peptides and Proteins 0
Membrane Proteins 0
RETREG1 protein, human 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

354-358

Informations de copyright

© 2019 Peripheral Nerve Society.

Références

Dyck PJ. Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy. 3rd ed. Philadelphia: W.B. Saunders; 1993:1065-1093.
Axelrod FB, Gold-von SG. Hereditary sensory and autonomic neuropathies: types II, III, and IV. Orphanet J Rare Dis. 2007;2:39.
Hilz MJ. Assessment and evaluation of hereditary sensory and autonomic neuropathies with autonomic and neurophysiological examinations. Clin Auton Res. 2002;12(Suppl 1):I33-I43.
Kurth I. Hereditary sensory and autonomic neuropathy type II. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, eds. GeneReviews® [Internet]. Seattle, WA: University of Washington; 2015.
Schwartzlow C, Kazamel M. Hereditary sensory and autonomic neuropathies: adding more to the classification. Curr Neurol Neurosci Rep. 2019;19:52.
Wakil S, Monies D, Hagos S, Al-Aijan FJ, Qahtani A, et al. Exome sequencing: mutilating sensory neuropathy with spastic paraplegia due to a mutation in FAM134B. Case Rep Genet. 2018;12:9468049.
Aydinlar EI, Rolfs A, Serteser M, Parman Y. Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a turkish family. Muscle Nerve. 2014;49(5):774-775.
Murphy MM, Davidson GL, Brandner S, Houlen H, Reilly MM. Mutation in FAM134B causing severe hereditary sensory neuropathy. J Neurol Neurosurg Psychiatry. 2012;83:119-120.
Kurth I, Pamminger T, Hennings CJ, et al. Mutations in FAM134B, enconding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy. Nat Genet. 2009;41(11):1179-1181.
Rotthier A, Baets J, De Vriendt E, et al. Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain. 2009;132:2699-2711.
Rotthier A, Auer-Grumbach M, Janssens K, et al. Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Am J Hum Genet. 2010;87:513-522.
Leonardis L, Auer-Grumbach M, Papić ZJ. The N355K atlastin 1 mutation is associated with hereditary sensor neuropathy and pyramidal tract features. Eur J Neurol. 2012;19(7):992-998.

Auteurs

Catarina Falcão de Campos (C)

Department of Neurosciences and Mental Health, Department of Neurology, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal.

Marie Vidailhet (M)

APHP, GH Pitié-Salpêtrière, Department of Neurology, ICM and Sorbonne University, Paris, France.

Annick Toutain (A)

Genetics Department, University Hospital, UMR 1253 iBrain, Inserm, Université de Tours, Tours, France.

Alix de Becdelièvre (A)

APHP, Hôpital Henri Mondor, Department of Medical Genetics, Université Paris-Est-Créteil, Inserm UMR955, Créteil, France.

Benoît Funalot (B)

APHP, Hôpital Henri Mondor, Department of Medical Genetics, Université Paris-Est-Créteil, Inserm UMR955, Créteil, France.

Nathalie Bonello-Palot (N)

APHM, Hôpital de la Timone, Department of Medical Genetics, Marseille, France.

Tanya Stojkovic (T)

APHP, GH-Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH